Works matching IS 02683369 AND DT 2010 AND VI 45

Results: 324

Repeated course of rituximab for treatment of nephrotic syndrome in patients with chronic GVHD.

Published in:

2010

By:

Mellon-Reppen, S.;
Ratanatharathorn, V.;
Cronin, S.;
Uberti, J. P.

Publication type:

Letter

Dismal response to high-dose methylprednisolone after failure to respond to standard dose in patients with acute GVHD.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1749, doi. 10.1038/bmt.2010.47

By:

Schechter, T.;
Macartney, C.;
Finkelstein, Y.;
Gassas, A.;
Husain, M.;
Doyle, J.;
Dupuis, L. L.

Publication type:

Article

Hematopoietic SCT for the treatment of multiple sclerosis.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1671, doi. 10.1038/bmt.2010.168

By:

Atkins, H.

Publication type:

Article

CD34<sup>+</sup> cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1699, doi. 10.1038/bmt.2010.49

By:

Holtan, S. G.;
Hogan, W. J.;
Elliott, M. A.;
Ansell, S. M.;
Inwards, D. J.;
Porrata, L. F.;
Johnston, P. B.;
Micallef, I. N.;
Lacy, M. Q.;
Gastineau, D. A.;
Litzow, M. R.

Publication type:

Article

The impact of novel influenza A (H1N1) after hematopoietic SCT.

Published in:

2010

By:

Patel, P.;
Sweiss, K.;
Shatavi, S.;
Peace, D.;
Clark, N.;
Rondelli, D.

Publication type:

Letter

Prognostic impact of serum ferritin concentration on survival following reduced-intensity conditioned allogeneic haemopoietic SCT.

Published in:

2010

By:

Oakes, R.;
Sood, Nitin;
Pearce, R.;
Swirsky, D.;
Cook, G.;
Gilleece, M.

Publication type:

Letter

Mesenchymal stem cell as salvage treatment for refractory chronic GVHD.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1732, doi. 10.1038/bmt.2010.195

By:

Weng, J. Y.;
Du, X.;
Geng, S. X.;
Peng, Y. W.;
Wang, Z.;
Lu, Z. S.;
Wu, S. J.;
Luo, C. W.;
Guo, R.;
Ling, W.;
Deng, C. X.;
Liao, P. J.;
Xiang, A. P.

Publication type:

Article

Bevacizumab in combination with sequential high-dose chemotherapy in solid cancer, a feasibility study.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1704, doi. 10.1038/bmt.2010.50

By:

Jordan, K.;
Wolf, H. H.;
Voigt, W.;
Kegel, T.;
Mueller, L. P.;
Behlendorf, T.;
Sippel, C.;
Arnold, D.;
Schmoll, H. J.

Publication type:

Article

Glutathione S-transferase T1-null seems to be associated with graft failure in hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1728, doi. 10.1038/bmt.2010.61

By:

Elhasid, R.;
Krivoy, N.;
Rowe, J. M.;
Sprecher, E.;
Efrati, E.

Publication type:

Article

Outcome and treatment of late-onset noninfectious pulmonary complications after allogeneic haematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1719, doi. 10.1038/bmt.2010.48

By:

Ueda, K.;
Watadani, T.;
Maeda, E.;
Ota, S.;
Kataoka, K.;
Seo, S.;
Kumano, K.;
Hangaishi, A.;
Takahashi, T.;
Imai, Y.;
Ohtomo, K.;
Fukayama, M.;
Nannya, Y.;
Kurokawa, M.

Publication type:

Article

Hematopoietic SCT activity in Asia: a report from the Asia-Pacific Blood and Marrow Transplantation Group.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1682, doi. 10.1038/bmt.2010.34

By:

Yoshimi, A.;
Suzuki, R.;
Atsuta, Y.;
Iida, M.;
Lu, D.-P.;
Tong, W.;
Ghavamzadeh, A.;
Alimoghaddam, K.;
Lie, A. K. W.;
Liang, R.;
Chan, L. L.;
Haipeng, L.;
Tan, P.-L.;
Hwang, W. Y. K.;
Chiou, T.-J.;
Chen, P.-M.;
Van Binh, T.;
Minh, N. N.;
Min, C.-K.;
Hwang, T. J.

Publication type:

Article

UVA (UVA-1) therapy for the treatment of acute GVHD of the skin.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1741, doi. 10.1038/bmt.2010.230

By:

Schlaak, M.;
Schwind, S.;
Wetzig, T.;
Maschke, J.;
Treudler, R.;
Basara, N.;
Lange, T.;
Simon, J. C.;
Niederwieser, D.;
Al-Ali, H. K.

Publication type:

Article

Feasibility of clofarabine cytoreduction before allogeneic transplant conditioning for refractory AML.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1692, doi. 10.1038/bmt.2010.32

By:

Locke, F. L.;
Artz, A.;
Rich, E.;
Zhang, Y.;
van Besien, K.;
Stock, W.

Publication type:

Article

Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1710, doi. 10.1038/bmt.2010.38

By:

Blennow, O.;
Remberger, M.;
Klingspor, L.;
Omazic, B.;
Fransson, K.;
Ljungman, P.;
Mattsson, J.;
Ringdén, O.

Publication type:

Article

Sustained CR of refractory aggressive natural killer cell leukemia following unrelated cord blood transplantation.

Published in:

2010

By:

Nishizawa, M.;
Sugino, N.;
Matsui, Y.;
Kaneko, H.;
Watanabe, M.;
Miura, Y.;
Tsudo, M.

Publication type:

Letter

Attainment of at least a very good partial response after induction treatment is an important surrogate of longer survival for multiple myeloma.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 11, p. 1625, doi. 10.1038/bmt.2010.25

By:

Tan, D.;
Lao, Z.;
Loh, Y.;
Ng, H. J.;
Chuah, C.;
Wong, G. C.;
Koh, M.;
Linn, Y. C.;
Lim, L. C.;
Tien, S. L.;
Lee, L. H.;
Goh, Y. T.;
Hwang, W.

Publication type:

Article

Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 11, p. 1653, doi. 10.1038/bmt.2010.15

By:

Cuvelier, G. D. E.;
Kariminia, A.;
Fujii, H.;
Aslanian, S.;
Wall, D.;
Goldman, F.;
Grupp, S. A.;
Dunn, S. E.;
Krailo, M.;
Shapiro, L. H.;
Gilman, A.;
Schultz, K. R.

Publication type:

Article

Identification of molecular markers for pre-engraftment immune reactions after cord blood transplantation by SELDI-TOF MS.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 11, p. 1594, doi. 10.1038/bmt.2010.18

By:

Morita-Hoshi, Y.;
Mori, S.-I.;
Soeda, A.;
Wakeda, T.;
Ohsaki, Y.;
Shiwa, M.;
Masuoka, K.;
Wake, A.;
Taniguchi, S.;
Takaue, Y.;
Heike, Y.

Publication type:

Article

Plasma brain natriuretic peptide is associated with hepatic veno-occlusive disease and early mortality after allogeneic hematopoietic stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 11, p. 1631, doi. 10.1038/bmt.2010.26

By:

Kataoka, K.;
Nannya, Y.;
Iwata, H.;
Seo, S.;
Kumano, K.;
Takahashi, T.;
Nagai, R.;
Kurokawa, M.

Publication type:

Article

SDF-1/CXCR4 blockade to mobilize hematopoietic progenitor cells from the placenta.

Published in:

2010

By:

Jing, D.;
Alakel, N.;
Bornhäuser, M.;
Ehninger, G.;
Ordemann, R.

Publication type:

Letter

Role of allo-SCT for CML in 2010.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 11, p. 1579, doi. 10.1038/bmt.2010.138

By:

Venepalli, N.;
Rezvani, K.;
Mielke, S.;
Savani, B. N.

Publication type:

Article

The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 11, p. 1587, doi. 10.1038/bmt.2010.14

By:

Stewart, W. A.;
Pearce, R.;
Kirkland, K. E.;
Bloor, A.;
Thomson, K.;
Apperley, J.;
McQuaker, G.;
Marks, D. I.;
Craddock, C.;
McCann, S.;
Russell, N.;
Cook, G.;
Kottaridis, P. D.

Publication type:

Article

Second allo-SCT from a different donor can improve severe steroid-resistant gut GVHD.

Published in:

2010

By:

Ustun, C.;
Jillella, A.;
Shah, R.;
Sterling, K.;
Deremer, D.;
Savage, N.;
Awan, F.;
Gossage, J. R.;
Dillard, T.;
Martin, P. J.

Publication type:

Letter

Outcome of allo-SCT for women with MDS or AML occurring after breast cancer therapy.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 11, p. 1611, doi. 10.1038/bmt.2010.20

By:

Armand, P.;
Kim, H. T.;
Mayer, E.;
Cutler, C. S.;
Ho, V. T.;
Koreth, J.;
Alyea, E. P.;
Antin, J. H.;
Soiffer, R. J.

Publication type:

Article

Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 11, p. 1645, doi. 10.1038/bmt.2010.28

By:

Carvalho, A.;
Cunha, C.;
Di Ianni, M.;
Pitzurra, L.;
Aloisi, T.;
Falzetti, F.;
Carotti, A.;
Bistoni, F.;
Aversa, F.;
Romani, L.

Publication type:

Article

Natural killer-cell KIR repertoire reconstitution after haploidentical SCT.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 11, p. 1607, doi. 10.1038/bmt.2010.19

By:

Stern, M.;
de Angelis, C.;
Urbani, E.;
Mancusi, A.;
Aversa, F.;
Velardi, A.;
Ruggeri, L.

Publication type:

Article

The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 11, p. 1618, doi. 10.1038/bmt.2010.24

By:

Littera, R.;
Orrù, N.;
Vacca, A.;
Bertaina, A.;
Caocci, G.;
Mulargia, M.;
Giardini, C.;
Piras, E.;
Mastronuzzi, A.;
Vinti, L.;
Orrù, S.;
Locatelli, F.;
Carcassi, C.;
La Nasa, G.

Publication type:

Article

Successful engraftment of a second transplant from unrelated cord blood identifying acceptable HLA Ag mismatches as treatment for primary graft failure possibly mediated by anti-HLA Abs after 'mega-dose' haploidentical PBSC transplantation.

Published in:

2010

By:

Hoshino, T.;
Sakura, T.;
Miyawaki, K.;
Hatsumi, N.;
Takada, S.;
Maruya, E.;
Saji, H.;
Miyawaki, S.

Publication type:

Letter

Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 11, p. 1602, doi. 10.1038/bmt.2010.31

By:

Kussmaul, S. C.;
Horn, B. N.;
Dvorak, C. C.;
Abramovitz, L.;
Cowan, M. J.;
Weintrub, P. S.

Publication type:

Article

Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto-SCT successfully treated with combination therapy.

Published in:

2010

By:

Fianchi, L.;
Colosimo, C.;
De Luca, A.;
Pompucci, A.;
Cattani, P.;
Voso, M. T.;
LaRocca, L. M.;
Leone, G.;
Pagano, L.

Publication type:

Letter

Palonosetron to prevent nausea and vomiting in children undergoing BMT: efficacy and safety.

Published in:

2010

By:

Ripaldi, M.;
Parasole, R.;
De Simone, G.;
D'Amico, M. R.;
Migliorati, R.;
Zanotta, G.;
Loffredo, G.;
Petruzziello, F.;
Poggi, V.

Publication type:

Letter

Donor-derived DNA in hair follicles of recipients after allogeneic hematopoietic stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 11, p. 1638, doi. 10.1038/bmt.2010.27

By:

Jacewicz, R.;
Lewandowski, K.;
Rupa-Matysek, J.;
Jedrzejczyk, M.;
Brzezinski, P. M.;
Dobosz, T.;
Jonkisz, A.;
Szram, S.;
Komarnicki, M.;
Berent, J.

Publication type:

Article

Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 10, p. 1479, doi. 10.1038/bmt.2010.134

By:

Meyers, G.;
Maziarz, R. T.

Publication type:

Article

Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 10, p. 1528, doi. 10.1038/bmt.2009.383

By:

Ozyilmaz, E.;
Aydogdu, M.;
Sucak, G.;
Aki, S. Z.;
Ozkurt, Z. N.;
Yegin, Z. A.;
Kokturk, N.

Publication type:

Article

Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 10, p. 1502, doi. 10.1038/bmt.2009.375

By:

Krishnamurthy, P.;
Lim, Z. Y.;
Nagi, W.;
Kenyon, M.;
Mijovic, A.;
Ireland, R.;
Marsh, J.;
Ho, A. Y. L.;
Mufti, G. J.;
Pagliuca, A.

Publication type:

Article

Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 10, p. 1534, doi. 10.1038/bmt.2010.5

By:

Pallua, S.;
Giesinger, J.;
Oberguggenberger, A.;
Kemmler, G.;
Nachbaur, D.;
Clausen, J.;
Kopp, M.;
Sperner-Unterweger, B.;
Holzner, B.

Publication type:

Article

Voriconazole or itraconazole for antifungal prophylaxis in patients with grade II-IV acute or extensive chronic graft-versus-host disease.

Published in:

2010

By:

Marks, D.;
Kibbler, C.;
Cook, G.;
Pagliuca, A.;
Reisman, A.;
Miller, P.;
Kantecki, M.;
Schlamm, H.

Publication type:

Correction Notice

The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 10, p. 1514, doi. 10.1038/bmt.2010.3

By:

Wu, G. Q.;
Zhao, Y. M.;
Lai, X. Y.;
Luo, Y.;
Tan, Y. M.;
Shi, J. M.;
Li, L.;
Zheng, W. Y.;
Zhang, J.;
Hu, X. R.;
Jin, A. Y.;
He, J. S.;
Xie, W. Z.;
Ye, X. J.;
Cai, Z.;
Lin, M. F.;
Huang, H.

Publication type:

Article

Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 10, p. 1508, doi. 10.1038/bmt.2009.378

By:

Yagasaki, H.;
Takahashi, Y.;
Hama, A.;
Kudo, K.;
Nishio, N.;
Muramatsu, H.;
Tanaka, M.;
Yoshida, N.;
Matsumoto, K.;
Watanabe, N.;
Kato, K.;
Horibe, K.;
Kojima, S.

Publication type:

Article

Fatal H1N1 influenza infection in an allo-SCT recipient.

Published in:

2010

By:

Rozovski, U.;
Herishanu, Y.;
Gipstein, L.;
Naparstek, E.

Publication type:

Letter

Hexaminolevulinate-mediated photodynamic purging of leukemia cells from BM.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 10, p. 1553, doi. 10.1038/bmt.2009.382

By:

Čunderlíková, B.;
Vasovič, V.;
Sieber, F.;
Furre, T.;
Nesland, J. M.;
Peng, Q.

Publication type:

Article

CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 10, p. 1489, doi. 10.1038/bmt.2009.381

By:

Jing, D.;
Oelschlaegel, U.;
Ordemann, R.;
Hölig, K.;
Ehninger, G.;
Reichmann, H.;
Ziemssen, T.;
Bornhäuser, M.

Publication type:

Article

Retrospective comparison of the effects of filgrastim and pegfilgrastim on the pace of engraftment in auto-SCT patients.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 10, p. 1522, doi. 10.1038/bmt.2009.373

By:

Mathew, S.;
Adel, N.;
Rice, R. D.;
Panageas, K.;
Duck, E. T.;
Comenzo, R. L.;
Kewalramani, T.;
Nimer, S. D.

Publication type:

Article

Hematopoietic SCT modulates gut inflammation in experimental inflammatory bowel disease.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 10, p. 1562, doi. 10.1038/bmt.2010.6

By:

Godoi, D. F.;
Cardoso, C. R.;
Ferraz, D. B.;
Provinciatto, P. R.;
Cunha, F. Q.;
Silva, J. S.;
Voltarelli, J. C.

Publication type:

Article

Allogeneic hematopoietic SCT and mechanical heart valve: feasibility of reduced toxicity myeloablative conditioning.

Published in:

2010

By:

Prébet, T.;
Devillier, R.;
Fürst, S.;
Vey, N.;
Blaise, D.

Publication type:

Letter

HLA-matched sibling transplantation with BM and CD34<sup>+</sup>-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 10, p. 1497, doi. 10.1038/bmt.2009.374

By:

Cho, B. S.;
Eom, K. S.;
Kim, Y. J.;
Kim, H. J.;
Lee, S.;
Min, C. K.;
Cho, S. G.;
Min, W. S.;
Park, C. W.;
Kim, C. C.;
Lee, J. W.

Publication type:

Article

Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onset.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 10, p. 1540, doi. 10.1038/bmt.2010.12

By:

Moon, J. H.;
Kim, S. N.;
Kang, B. W.;
Chae, Y. S.;
Kim, J. G.;
Ahn, J. S.;
Kim, Y. K.;
Yang, D. H.;
Lee, J. J.;
Kim, H. J.;
Choi, Y. J.;
Shin, H. J.;
Chung, J. S.;
Cho, G. J.;
Sohn, S. K.

Publication type:

Article

Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 10, p. 1546, doi. 10.1038/bmt.2010.13

By:

Thiant, S.;
Yakoub-Agha, I.;
Magro, L.;
Trauet, J.;
Coiteux, V.;
Jouet, J.-P.;
Dessaint, J.-P.;
Labalette, M.

Publication type:

Article

Acute myocardial infarction in a 16-year-old girl with chronic GVHD.

Published in:

2010

By:

Miura, T.;
Izawa, A.;
Kumazaki, S.;
Ishii, E.;
Otagiri, K.;
Aizawa, K.;
Koshikawa, M.;
Kasai, H.;
Tomita, T.;
Miyashita, Y.;
Tsutsui, H.;
Koyama, J.;
Ikeda, U.

Publication type:

Letter

MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 9, p. 1449, doi. 10.1038/bmt.2009.362

By:

Piñana, J L;
Valcárcel, D;
Fernández-Avilés, F;
Martino, R;
Rovira, M;
Barba, P;
Martínez, C;
Brunet, S;
Sureda, A;
Carreras, E;
Sierra, J

Publication type:

Article